Chimeric clocks $4.17M R&D tax rebate from Canberra
Chimeric Therapeutics (ASX:CHM) has confirmed its receipt of a $4.17M tax rebate from Canberra for R&D activities.
RDV
0.31%
$29.13
RUSSELL HIGH DIVIDEND AUSTRALIAN SHARES ETF - Announcements
Currently unlisted.
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results